Breast Cancer Research

official impact factor 5.79

Download references

Open Access

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

Francisco J Esteva*, Jing Wang, Feng Lin, Jaime A Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U Buzdar, Gabriel N Hortobagyi, W Fraser Symmans and Lajos Pusztai

Breast Cancer Research 2007, 9:R87 doi:10.1186/bcr1836

Include


Format